Intensity Therapeutics, Inc (INTS) insider trading
Every open-market stock purchase and sale by Intensity Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $3.19 on Oct 22, 2026.
Recent INTS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 16, 2026 | John M Wesolowski (Officer) | Bought (not open market) | — |
| Jul 16, 2026 | Thomas I H Dubin (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Emer Leahy (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Daniel Donovan (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Joseph Talamo (CFO) | Bought (not open market) | — |
| Jul 16, 2026 | Mark A Goldberg (Director) | Bought (not open market) | — |
| Jul 16, 2026 | Lewis H Bender (CEO) | Bought (not open market) | — |
| Jun 30, 2026 | John M Wesolowski (Officer) | Bought (not open market) | $12.9K |
| Jun 30, 2026 | Joseph Talamo (CFO) | Bought (not open market) | $3.8K |
| Mar 26, 2026 | Lewis H Bender (CEO) | Bought (not open market) | $231K |
| Dec 31, 2025 | Joseph Talamo (CFO) | Bought (not open market) | $3.8K |
| Dec 31, 2025 | John M Wesolowski (Officer) | Bought (not open market) | $2.3K |
Who's trading INTS
- Lewis H Bender, CEO: other filings, last Jul 16, 2026
- Thomas I H Dubin, Director: other filings, last Jul 16, 2026
- Daniel Donovan, Director: other filings, last Jul 16, 2026
- Mark A Goldberg, Director: other filings, last Jul 16, 2026
- Emer Leahy, Director: other filings, last Jul 16, 2026
- Joseph Talamo, CFO: other filings, last Jul 16, 2026
- John M Wesolowski, Officer: other filings, last Jul 16, 2026
Get free alerts when an insider at Intensity Therapeutics, Inc files a new trade →